Screening

Revvity

ebook: TR-FRET assay kits simplify & accelerate drug discovery

3 May 2023 | By BPS Bioscience

This ebook provides basic principles of the TR-FRET technology and shows examples of how assay design can drive drug discovery.

ebook: Never Miss A Hit – Unleash Your Drug Discovery With A Label-Free Playlist

17 April 2023 | By Drug Target Review

Get ready to dive into the cutting-edge world of hit-to-lead drug discovery. Look no further than our latest FREE ebook, which explores label-free HTL technologies. Featuring the latest research from leading academics and pharmaceutical companies, including GlaxoSmithKline, Rosalind Franklin Institute and Francis Crick Institute.

Combination therapy prevails against BET inhibitor resistance

13 April 2023 | By Taylor Mixides (Drug Target Review)

St. Jude Children's Research Hospital, US, scientists created a new combination therapy method to tackle drug resistance in a type of leukaemia with KMT2A gene rearrangement.

Webinar: The Role of Neuronal Metabolism in Early Drug Discovery

4 April 2023 | By Agilent

Learning about the mitochondrial role in a neurodegenerative disorder.

Researchers develop screening model to evaluate potential cervical cancer drugs

4 April 2023 | By Ria Kakkad (Drug Target Review)

Oregon State University researchers have developed a screening model for rapid testing of multiple drug compounds, using a 3D cellular platform.

Assay performance and the Z’-factor in HTS

30 March 2023 | By Dr Matthew Lloyd (University of Bath)

Matthew Lloyd from the University of Bath reveals the importance of the Z-factor and Z’-factor in high-throughput screening, and how they can be used to determine assay performance, perform quality control on the screen, and identify active compounds.

De-risking drugs in multiplex assays before progressing to clinical trials

30 March 2023 | By Dr Sheraz Gul (Fraunhofer Institute)

Sheraz Gul, Head of Assay Development and Drug Repurposing at the Fraunhofer Institute, discusses the importance of performing comprehensive multiplex spatial and temporal profiling of drugs in pre-clinical research to decrease the risk of potentially undesirable events in later clinical studies.

Application note: Revolutionising drug formulations with polysorbate detection

30 March 2023 | By Halo Labs

Transform your drug manufacturing process with the latest breakthroughs in technology. Effortlessly identify and differentiate degradation components of PS20 in protein-containing samples.

Drug Target Review Assays ebook 2023

29 March 2023 | By Drug Target Review

Download your FREE ebook on assays, featuring articles from experts who write about developments in screening and the importance of performing comprehensive multiplex spatial and temporal profiling of drugs in pre-clinical research.

Drug Target Review – Issue 1 2023

29 March 2023 | By Drug Target Review

A new Drug Target Review is now ready to download! This issue features articles which explore antibodies, vaccines and assays.

Whitepaper: PSMA Protein in the Battle Against Cancer

20 March 2023 | By Bio-Techne

The PSMA Protein is a new therapeutic hot target. In this article, learn about its growing role in the fight against prostate cancer and beyond.

Accelerating hit finding programs: Echo MS and RapidFire-MS key advantages

16 March 2023 | By Eurofins Discovery Services

In this on-demand webinar, we present the most advanced label-free technologies in identifying successful hit series for Hit-to-Lead and Lead-Optimization programs.

Webinar: Accurate detection of mitochondrial toxicity

7 March 2023 | By Agilent

Using Agilent Seahorse XF technology with the XF Mito Tox Assay allows for streamlined, reliable identification of mitochondrial toxicants.

Video: Spatial imaging as a tool for discovery

2 March 2023 | By Cell SIgnaling Technology

Watch Dr David Rimm from the Yale School of Medicine talk about his recent work and take on the future of multiplex spatial profiling of the TME.